BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33995507)

  • 1. Uric acid is associated with cardiac death in patients with hypertrophic obstructive cardiomyopathy.
    Gao J; Shao CL; Meng XB; Wang WY; Zhang K; Wang JJ; Zheng MQ; Tang YD
    J Geriatr Cardiol; 2021 Apr; 18(4):281-288. PubMed ID: 33995507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of Free Triiodothyronine Level in Patients With Hypertrophic Obstructive Cardiomyopathy.
    Zhang K; Meng X; Wang W; Zheng J; An S; Wang S; Qi Y; Gao C; Tang YD
    J Clin Endocrinol Metab; 2018 Mar; 103(3):1198-1205. PubMed ID: 29304228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Uric Acid as a Prognostic Marker in Patients With Hypertrophic Cardiomyopathy.
    Zhu L; Wang J; Wang Y; Jia L; Sun K; Wang H; Zou Y; Tian T; Liu Y; Zou J; Hui R; Yuan Z; Song L
    Can J Cardiol; 2015 Oct; 31(10):1252-8. PubMed ID: 26111667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age, creatinine clearance, and ejection fraction (mACEF) score predicts long-term cardiac mortality in patients with hypertrophic obstructive cardiomyopathy treated non-invasively.
    Gao J; Shao C; Wang W; Meng X; Zhang K; Wang J; Zheng M; Tang YD
    Anatol J Cardiol; 2021 Oct; 25(10):691-698. PubMed ID: 34622783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of surgical septal myectomy on survival in patients with hypertrophic obstructive cardiomyopathy.
    Meng X; Liang M; Shi Y; Zhang W; Zhou S; Gao C
    Anatol J Cardiol; 2020 Jun; 23(6):342-348. PubMed ID: 32478684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term outcome of patients with hypertrophic obstructive cardiomyopathy post percutaneous transluminal septal ablation].
    Zheng SW; Shi HY; Dai JJ; Chen H; Wu WH; Qiu XB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):294-301. PubMed ID: 32370480
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in uric acid levels and allopurinol use in chronic heart failure: association with improved survival.
    Gotsman I; Keren A; Lotan C; Zwas DR
    J Card Fail; 2012 Sep; 18(9):694-701. PubMed ID: 22939038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obstructive sleep apnea is associated with nonsustained ventricular tachycardia in patients with hypertrophic obstructive cardiomyopathy.
    Wang S; Cui H; Song C; Zhu C; Wu R; Meng L; Yu Q; Huang X; Wang S
    Heart Rhythm; 2019 May; 16(5):694-701. PubMed ID: 30576881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between uric acid and cardiac outcomes mediated by neutrophil-to-lymphocyte ratio in patients with left ventricular diastolic dysfunction and pulmonary hypertension.
    Du P; Gao X; Sun Q; Gong M; Pan Y; Guo Q; Zhao X; Guo R; Liu Y
    Sci Rep; 2024 Feb; 14(1):2751. PubMed ID: 38302600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy and safety of transthoracic echocardiography-guided percutaneous intramyocardial septal radiofrequency ablation for the treatment of patients with obstructive hypertrophic cardiomyopathy].
    Liu LW; Zuo L; Zhou MY; Li J; Zhou XD; He GB; Zhang J; Zhang JZ; Liu B; Yang J; Xu B
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Apr; 47(4):284-290. PubMed ID: 31060187
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiac troponin I is associated with non-sustained ventricular tachycardia in patients with hypertrophic obstructive cardiomyopathy.
    Zhou Y; Yu M; Yuan J; Liu S; Hu F; Yang Z; Cui J; Qiao S
    Heart Vessels; 2020 Jun; 35(6):876-885. PubMed ID: 31907598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term outcome and related predictors of alcohol septal ablation for patients with hypertrophic obstructive cardiomyopathy].
    Liu R; Qiao SB; Hu FH; Yang WX; Yuan JS; Cui JG
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Sep; 44(9):771-776. PubMed ID: 27667275
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of the association between serum uric acid level andthe predicted risk score of sudden cardiac death in five years in patients with hypertrophic cardiomyopathy.
    Özyılmaz S; Satılmışoğlu MH; Gül M; Uyarel H; Serdar OA
    Turk Kardiyol Dern Ars; 2018 Mar; 46(2):111-120. PubMed ID: 29512627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cibenzoline on regional left ventricular function in hypertrophic obstructive cardiomyopathy.
    Kondo I; Mizushige K; Nozaki S; Hirao K; Iwado Y; Ohmori K; Matsuo H
    Clin Cardiol; 2000 Sep; 23(9):689-96. PubMed ID: 11016020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
    Nakamura T; Iwanaga Y; Yasuda M; Kawamura T; Miyaji Y; Morooka H; Miyazaki S
    Int J Cardiovasc Imaging; 2016 Apr; 32(4):613-20. PubMed ID: 26589516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of long-term outcomes in symptomatic hypertrophic obstructive cardiomyopathy patients undergoing surgical relief of left ventricular outflow tract obstruction.
    Desai MY; Bhonsale A; Smedira NG; Naji P; Thamilarasan M; Lytle BW; Lever HM
    Circulation; 2013 Jul; 128(3):209-16. PubMed ID: 23770748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up impact of dual-chamber pacing on patients with hypertrophic obstructive cardiomyopathy.
    Yue-Cheng H; Zuo-Cheng L; Xi-Ming L; Yuan DZ; Dong-Xia J; Ying-Yi Z; Hui-Ming Y; Hong-Liang C
    Pacing Clin Electrophysiol; 2013 Jan; 36(1):86-93. PubMed ID: 23078085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of conservative and invasive treatment in patients with hypertrophic obstructive cardiomyopathy.
    Hoedemakers S; Vandenberk B; Liebregts M; Bringmans T; Vriesendorp P; Willems R; Van Cleemput J
    Acta Cardiol; 2019 Jun; 74(3):253-261. PubMed ID: 30451084
    [No Abstract]   [Full Text] [Related]  

  • 19. Incremental Prognostic Utility of Left Ventricular Global Longitudinal Strain in Hypertrophic Obstructive Cardiomyopathy Patients and Preserved Left Ventricular Ejection Fraction.
    Tower-Rader A; Betancor J; Popovic ZB; Sato K; Thamilarasan M; Smedira NG; Lever HM; Desai MY
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29054839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial mechanical remodeling after septal myectomy for severe obstructive hypertrophic cardiomyopathy.
    Moravsky G; Bruchal-Garbicz B; Jamorski M; Ralph-Edwards A; Gruner C; Williams L; Woo A; Yang H; Laczay B; Rakowski H; Carasso S
    J Am Soc Echocardiogr; 2013 Aug; 26(8):893-900. PubMed ID: 23800507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.